In vertebrates, 5-HT participates in the regulation of var ious physiologic functions, including pain perception, blood pressure, sleep, homeothermia, and sexual ac ti vity. It is also believed that 5-HT may participate in the expression of symptoms of certain psychiatric dis orders, such as depression and anxiety. In this context, most of our knowledge concerning the participation of S-HT and 5-HT receptors in psychopathology has come from the characterization of the mechanisms of action of various drugs that are effective in relieving the symp toms of psychiatric disorders.
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That the 5-HT receptor population in the periph e ry might be heterogeneous was fIrst suggested by the earl y pioneering work of two independent groups (Rocha e Silva et a1. 1953; Gaddum and Hameed 1954) .
It was not until the late 1970s, however, that Peroutka and Snyder (1979) described, in the eNS, the existence of two diff erent 5-HT recognition sites labeled by lyser gic acid diethylamine, the serotonin-1 (5-HT1) and the serotonin-2 (5-HT2) binding sites. 5-HTIA, 5-HTIB, 5-HTlC, 5-HTm, and 5-HTIE (Pedigo et al. 1981; Pazos et al. 1984; Peroutka 1986; Heuring and Peroutka 1987; Leonhardt et a1. 1989) . The recep tor status of the 5-HTIE subtype, however, is still a pending question. In contrast, the 5-HT2 site was characterized as a 5-HT receptor with low (micromo lar) affinity for 5-HT but high (nanomolar) affinity for a series of compounds (ketanserin, ritanserin, cinanse rin, and spiperone) (Bradley et a1. 1985; Glennon 1987) that antagonize certain behavioral responses elicited by the administration of 5-HT-mimetic drugs (Peroutka et al. 1981) .
A third type of 5-HT receptor, the 5-HT3 recogni tion site, has also been identifIed (Fozard et a1. 1979; Fozard 1984; Richardson et a1. 1985; Hoyer and Neijt 1987; Kilpatrick et al. 1987; Resier and Hamprecht 1989; Peters and Lambert 1989; Barnes et a1. 1989a ). The 5-HT3 receptor, which represents the so-called "M"
receptor identifIed by Gaddum and Piccarelli (1957) in the guinea pig intestine, was initially described in pe ripheral neurons in which it mediates depolarization of neurotransmitter release (Bradley et a1. 1985) . More recently, 5-HT3 binding sites were also identifIed in neuronal cell lines (Hoyer and Neijt 1987; Resier and Hamprecht 1989; Peters and Lambert 1989) , in discrete brain areas (Kilpatrick et a1. 1987; Barnes et al. 1988; Peroutka and Hamik 1988; Barnes et al. 1989a; Waeber et a1. 1989) , and in the spinal cord (Glaum and Ander son 1988; Hamon et a1. 1989) . Whether these binding 0893-133X/93/$6.00
sites represent functional receptors and meet the criteria for 5-HT3 receptors (Bradley et al. 1985) has been ad dressed by a series of studies showing behavioral, bio chemical, and electro physiologic responses to both 5-HT3 agonist and antagonist drugs (Costall et al. 1987 (Costall et al. , 1990 Blandina et al. 1988; Barnes et al. 1989b; Blandina et al. 1989; Imperato et al. 1989; Peters and Lambert 1989; Hagan et al. 1990 ).
A 5-HT receptor that does not meet the criteria for a 5-HTl, 5-HT2, or 5-HT3 receptor has also been re cently described. This receptor, which is found in mouse embryo colliculi neurons and in the guinea pig hippocampus, has been classifIed as 5-HT4 (Dumuis et al. 1988) . A series of different putative 5-HT receptors (5-HTlp, drosophila 5-HT receptor, the tryptamine preferring receptors of the invertebrates, the stomach fundus receptor) have also been identifIed in periph eral tissues of vertebrates and invertebrates.
The 5-HTl, 5-HT2, and 5-HT4 receptors are coupled to second messenger systems. Activation of 5-HTIA, 5-HTIB, and 5-HT1O receptors inhibits, whereas activa tion of the 5-HT4 receptor stimulates, adenylate cyclase (Bradley et al. 1985; Dumuis et al. 1988 ). On the other hand, activation of both 5-HTIC and 5-HT2 receptors increases phosphoinositide (PI) metabolism (Conn and Sanders-Bush 1984; Conn et al. 1986; Nakaki et al. 1984) .
It was also shown recently that 5-HT3 receptor activa tion stimulates PI hydrolysis in the rat cortex (Edwards et al. 1991) . Whether the increase of PI turnover is the result of a direct 5-HT3 receptor-mediated mechanism or else an indirect effect mediated through a still un known pathway is not yet clearly understood.
In the last several years, the 5-HTIA, 5-HTIC, 5-HT1O, and 5-HT2 receptors have been cloned (Fargin et aI. 1988; Julius et al. 1988; Pritchett et al. 1988; Ham blin and Metcalf 1991) . More recently, the 5-HT3 recep tor has also been cloned (Maricq et al. 1991) . The char acteristics of the cloned 5-HT3 receptor are largely consistent with the properties of the purifIed receptor obtained from brain tissue and neural tumor cell lines (McKernan et al. 1990a (McKernan et al. , 1990b Miquel et aI. 1990 ) (see below).
DEVELOPMENT OF SELECTIVE DRUGS ACTIVE AT THE 5-HT3 RECEPTOR
It has long been known that both morphine and cocaine block the excitatory action of 5-HT on peripheral neu rons (Rocha e Silva et al. 1953; Gaddum and Hameed 1954) . Only recently, however, was evidence presented indicating that both drugs induce their effects via a specifIc competitive antagonistic action on 5-HT3 receptors . Further studies demon strated that metoclopramide and a series of substituted benzamides (Fozard et al. 1978; Fozard 1984 ) also be-
have as competitive antagonists of 5-HT action on pe ripheral tissues possessing 5-HT3 receptors.
The broad pharmacologic profIles of compounds with affinity for the neural 5-HT3 receptor hampered the defInition of this receptor. By chemically substitut ing compounds that bind with rather low specifIcity to the 5-HT3 site, it became possible to synthesize selec tive 5-HT3 receptor agonists and antagonists (Fozard and Gittos 1983; Richardson et al. 1985; Fake et al. 1987 ).
On the basis of the assumption that different confor mations of the 5-HT molecule are required for activa tion of the so-called "0" receptor antagonist (Fozard and Gittos 1983; Fozard 1984a ).
By restricting the conformational freedom of the diethylaminoethyl side chain and changing the aromatic nucleus of the metoclopramide molecule, a series of 3-indazole carboxamides was obtained, Among these compounds, endo-N-(9-methyl-9-azabicyclo [3,3,I] non-3-yl)-I-methyl-imidazole-carboxamide (BRL 43694) was found to possess potent and selective 5-HT3 antagonis tic properties (Fake et al. 1987 ).
Other compounds with selective activity at the 5-HT3 receptor have also been identifIed. Among them, 1,2,3, 9-tetrahydro-9-methyl-3[ (2-methyl-lH-imidazol l-yl)methyl]-4H-carbazol-4-1 hydrochloride hydrate (GR38032) (Butler et aI. ' 1988) and 4-amino-N-(1-azabicyclo[2,2.2.]oct-yl)-5-chloro-2-methoxybenzamide hydrochloride hydrate (zacopride) (Smith et al. 1988) also proved to be potent 5-HT3 receptor antagonists.
Quipazine possesses high affInity for the 5-HT3 bind ing site in nervous tissue (Peroutka and Hamik 1988) but also binds with relatively high affInity to other 5-HT receptors (Glennon et al. 1986 ).
Recently a computer-aided molecular modeling were consistent with those expected for a 5-HT3 recep tor (Bradley et a1. 1985) . Moreover, the inability of ade nine and guanine nucleotides to affect agonist binding suggests that 5-HT3 recognition sites are not coupled to G-proteins (Hoyer and Neijt 1988) .
The identification and characterization of binding sites in the rat brain support the notion that the behavioral effects observed in rats after the adminis tration of drugs selective for 5-HT3 receptors might be mediated by a central rather than a peripheral 5-HT3
receptor. After Kilpatrick et al. (1987) first demonstrated the presence of [ 3 H]GR65630 binding sites in rat brain, the putative rat brain 5-HT3 receptor was characterized with the use of other different radioligands Pratt and Bowery 1989; Reynolds et a1. 1989; Schmidt et a1. 1988; Watling 1988; Waeber et al. 1989; Watling et al. 1988; Barnes et al. 1988; Peroutka and Hamik 1988 Kilpatrick et a1. 1987 Kilpatrick et a1. , 1989 Kilpatrick et a1. , 1990 Peroutka 1988; Barnes et al. 1988; Watling et al. 1988) . Equilibrium satu ration analysis for the radioligands revealed that bind ing was to a single saturable high-affi.nity site. Binding was also reversible, stereospecific, and unevenly dis tributed throughout the rat CNS (see below) (Kilpatrick et al. 1987 Barnes et a1. 1988; Watling et al. 1988; Milburn and Peroutka 1989; Barnes et a1. 1990 ). The roleptics. This assumption, however, is not supported by preliminary studies, which showed that zacopride failed to modify positive symptoms in schizophrenic patients (Newcomer et al. 1990 ).
The 5-HT3 binding sites initially described in the rat brain and tumor cell lines were also found in the brains of other animal species, including humans (Peroutka 1988; Kilpatrick et al. 1989; Barnes et al. 1989a ). Specific binding of [ 3 H] In all species studied, the area postrema, which is the site of the chemoreceptor trigger zone, possesses the highest concentration of 5-HT3 binding sites (Pratt et al. 1990 ). In rat and mouse brain, high densities
[ 3 H]quipazine specific binding sites are present in the entorhinal, frontal, retrosplenic, cingulate, temporal, parietal, and occipital cortex and in the amygdala and hippocampus. In these same species, 5-HT3 specifIc binding sites are very low in number or undetectable in the nucleus accumbens, striatum, thalamus, hypo thalamus, and cerebellum (Kilpatrick et al. 1987 (Kilpatrick et al. , 1988 (Kilpatrick et al. , 1989 Milburn and Peroutka 1989; ). In rat spinal cord, 5-HT3 binding sites seem to be located presynaptically on capsaicin-sensitive pri· mary afferent fIbers (Glaum and Anderson 1988; Ha· mon et al. 1989) . Interestingly, the ferret possesses high concentrations of [ 3 H] GR65630 binding sites in the nu cleus accumbens, olfactory tubercle, amygdala, and stri atum (Kilpatrick et al. 1989 (Waeber et al. 1989) receptor identified in the corresponding membrane frac tions (Kilpatrick et al. 1987 (Kilpatrick et al. , 1989 Hoyer and Neijt 1988; ). Further studies led to the purifica tion of the solubilized receptor from the NCB20 neuro The apparent molecular mass of the purifIed 5-HT 3 receptor (250 kD) is in the same range as that determined for three ligand-gated ion channels: the gamma aminobutyric acid type A (GABAA) receptor (Sigel et al.1983; Stephenson 1988; Mamalaki et al. 1989) , the glycine receptor (Pfeiffer et al. 1982) , and the nicotonic acetylcholine (ACh) receptor (Whiting and Lindstrom 1986) . Considering the physicochemical similarities be-
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tween the 5-HT3 receptor and these three receptors, it was predicted that the 5-HT3 receptor belongs to the superfamily of ligand-gated ion channels. The recep tors in this family possess a heterooligomeric structure, probably comprising four or fIve subunits, which to gether form the hydrophilic pore of the ion-specific channel. lasted approximately 2 to 4 seconds .
CLONING OF THE 5-HT3 RECEPTOR
A similar fast depolarizing response to 5-HT is also ob served in clonal cell lines N eijt et al. 1988a; Yang 1990 ) and in Xenopus oocytes injected with RNA transcripts obtained from the 5-HT3 recep tor cDNA (Maricq et al. 1991) . The fast depolarizing cur rent evoked by 5-HT is reproduced by the 5-HT3 recep tor agonists 2-methyl-5-HT, 1-phenylbiguanide and l-(m-chlorophenyl) biguanide, and is antagonized by selective 5-HT3 receptor antagonists (Neijt et al. 1986 (Neijt et al. , 1988a Maricq et al. 1991 ). Both voltage-clamp studies and radioligand binding analysis indicate that 5-HT binds to the 5-HT3 receptor in a cooperative manner (Neijt et al. 1988a; Kil patrick et al. 1987; Hoyer et al. 1988; Maricq et al. 1991 ).
Thus, biochemical, molecular biological (see above), and electrophysiologic evidence (Hoyer and Neijt 1988; McKernan et al. 1990; Maricq et al. 1991) indicates that results in a fast excitatory 5-HT3 receptor-mediated re sponse Derkach et al. 1989 , Yang 1990 Maricq et al. 1991) .
Unlike other receptors for biogenic amines, both native and cloned 5-HT3 receptors are directly coupled to an ion channel that is permeable to the monovalent cations Na+ and K+ (Derkach et al. 1989; Yakel et al. 1990; Maricq et al. 1991) . Activation of 5-HT3 receptors in voltage-clamped membranes results in an opening of ligand-gated Na+-K+ channels with an increase in the inward current that flows through these channels (Peters and Usherwood 1983) . The large inward driv ing force for Na+ results in a greater Na+ influx and a reduced K+ efflux through the channel, with the can· sequence that the resting membrane potential ( -55 m V)
is progressively driven toward the Na+ equilibrium potential (+55 mY); however, when the membrane potential reaches around 0 m V (the reversal potenti al for the Na+-K+ ion channel), the inward Na+ current is reduced and the outward K+ current is increased Lambert et al. 1989) . sensitive glutamate receptor, the conductance of which is blocked by Mg2+ (Nowak et al. 1984 ).
The Ca2+ permeability and single-channel conduc tance of the 5-HT3 receptor-linked Na+-K+ channel in NGI08-15 cells are similar to those of the non-NMDA type of excitatory amino-acid receptor but lower than those of the nicotinic ACh receptor (Yakel et al. 1990 ).
In neuroblastoma N18 cells, however, the permeabil· ity ratio of the 5-HT3 receptor channel for Ca2+ is simi-lar to that of the nicotinic cholinergic receptor (Adams et al. 1980; Yang 1990 ).
Two types of desensitization kinetics after 5-HT ap plication have been observed for the 5-HT3 receptor.
In NIB-115 cells and in oocytes expressing cloned S-HT3 receptors, desensitization of the receptor is rapid (Neijt et al. 1988a; Maricq et al. 1991) 
BIOCHEMICAL RESPONSES TO 5-HT 3

RECEPTOR ACTIVATION
Neurotransmitter release and metabolism in the CNS is modified by 5-HT3 receptor-selective drugs (Blan dina et al. 1988 (Blan dina et al. , 1989 Barnes et al. 1989b; Imperato and Angelucci 1989; Hagan et al. 1990 ). In superfused rat striatal slices, Blandina et al. (1988 Blandina et al. ( , 1989 
5-HT3 RECEPTORS AND CENTRAL NERVOUS SYSTEM DISORDERS
The development of drugs that are selective for the 5-HT3 receptor, together with the availability of be- (Newcomer et al. 1990 ).
The mesolimbic system also seems to be important in the mechanisms by which substances with abuse potential produce their pharmacologic effects. The in crease in DA turnover in the nucleus accumbens after administration of morphine (Costa et al. 1973; Imper ato and Angelucci 1989), amphetamine (Costa and Gr opetti 1970; Costa et al. 1972; Costall et al. 1980 ), or cocaine (Costa et al. 1973 ) may contribute to the reward ing mechanisms (Wise and Bogharth 1988) and to the maintenance of psychologic dependency after adminis tration of these drugs of abuse (Costall et al. 1990 ). In terestingly, 5-HT3 receptor antagonists proved to be highly effective in reducing the consequences of with drawal after long-term treatment with a number of these drugs, including alcohol, anxiolytics, cocaine, ampheta mine, and nicotine (Oakley et al. 1988a (Oakley et al. , 1988b Costall et al. 1990) . Whether the effects of 5-HT3 receptor an tagonists are mediated through a reduction in the
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hyperactivation of the dopaminergic system induced by drugs of abuse is unknown.
A common feature of many experimental models that are responsive to 5-HT3 receptor antagonists is an increased activity of presynaptic dopaminergic neurons (Costall et al. 1987a (Costall et al. , 1987c (Costall et al. , 1990 Carboni et al. 1989b; Imperato and Angelucci 1989; Hagan et al. 1990 ). This common characteristic suggests that the activation of a serotonergic neuron that impinges on a dopaminer gic neuron (either at the presynaptic terminal, or on the cell body or a dendrite) represents a necessary step for the subsequent depolarization of the dopaminergic cell.
Thus , shown that zacopride exerts a mild anxiolytic effect without sedation and reduces the distress associated with psychotic symptoms (Newcomer et al. 1990 ).
The ability of GR38032F to facilitate ACh release in cortical tissue (Barnes et al. 1989b) receptors (Derkach et al. 1989; Lamberts et al. 1989; Yang 1990 ). In addition, at odds with the failure of the 5-HT3 receptor antagonist MDL 72222 to counteract the effect of 5-HT in enteric neurons, this compound rever sibly blocks the 5-HT-evoked current in Xenopus 00-cytes expressing the cloned 5-HT3 receptor (Maricq et al. 1991) . These data are consistent with the apparent absence of 5-HT3 receptor rnRNA in the mouse intes tine (Maricq et al. 1991 (Blandina et al. 1988 (Blandina et al. , 1989 Imperato and Angelucci 1989) 
